A philosopher asks whether therapy should be evaluated like drugs

The author, Sahanika Ratnayake, explores whether therapeutic interventions should be evaluated using the same randomized controlled trial (RCT) methodology applied to pharmaceuticals. The paper argues that the inherent characteristics of therapy—such as variability and individualization—make RCTs less suitable, suggesting that a more pluralistic evidence base is necessary for assessing therapeutic effectiveness.